BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 8823305)

  • 1. Mechanism of dexamethasone suppression of brain tumor-associated vascular permeability in rats. Involvement of the glucocorticoid receptor and vascular permeability factor.
    Heiss JD; Papavassiliou E; Merrill MJ; Nieman L; Knightly JJ; Walbridge S; Edwards NA; Oldfield EH
    J Clin Invest; 1996 Sep; 98(6):1400-8. PubMed ID: 8823305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular permeability induced by protein product of malignant brain tumors: inhibition by dexamethasone.
    Bruce JN; Criscuolo GR; Merrill MJ; Moquin RR; Blacklock JB; Oldfield EH
    J Neurosurg; 1987 Dec; 67(6):880-4. PubMed ID: 3681425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment for malignant pleural effusion of human lung adenocarcinoma by inhibition of vascular endothelial growth factor receptor tyrosine kinase phosphorylation.
    Yano S; Herbst RS; Shinohara H; Knighton B; Bucana CD; Killion JJ; Wood J; Fidler IJ
    Clin Cancer Res; 2000 Mar; 6(3):957-65. PubMed ID: 10741721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of vascular permeability factor (vascular endothelial growth factor) with antipeptide antibodies.
    Sioussat TM; Dvorak HF; Brock TA; Senger DR
    Arch Biochem Biophys; 1993 Feb; 301(1):15-20. PubMed ID: 8442657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uterine smooth muscle cells express functional receptors (flt-1 and KDR) for vascular permeability factor/vascular endothelial growth factor.
    Brown LF; Detmar M; Tognazzi K; Abu-Jawdeh G; Iruela-Arispe ML
    Lab Invest; 1997 Feb; 76(2):245-55. PubMed ID: 9042161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Up-regulation of vascular endothelial growth factor/vascular permeability factor in mouse skin carcinogenesis correlates with malignant progression state and activated H-ras expression levels.
    Larcher F; Robles AI; Duran H; Murillas R; Quintanilla M; Cano A; Conti CJ; Jorcano JL
    Cancer Res; 1996 Dec; 56(23):5391-6. PubMed ID: 8968091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro and in vivo angiogenesis in PC12 pheochromocytoma cells is mediated by vascular endothelial growth factor.
    Middeke M; Hoffmann S; Hassan I; Wunderlich A; Hofbauer LC; Zielke A
    Exp Clin Endocrinol Diabetes; 2002 Nov; 110(8):386-92. PubMed ID: 12518248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) delays and induces escape from senescence in human dermal microvascular endothelial cells.
    Watanabe Y; Lee SW; Detmar M; Ajioka I; Dvorak HF
    Oncogene; 1997 May; 14(17):2025-32. PubMed ID: 9160882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular endothelial growth factor/vascular permeability factor (VEGF/VPF) in normal and atherosclerotic human arteries.
    Couffinhal T; Kearney M; Witzenbichler B; Chen D; Murohara T; Losordo DW; Symes J; Isner JM
    Am J Pathol; 1997 May; 150(5):1673-85. PubMed ID: 9137092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytosolic calcium changes in endothelial cells induced by a protein product of human gliomas containing vascular permeability factor activity.
    Criscuolo GR; Lelkes PI; Rotrosen D; Oldfield EH
    J Neurosurg; 1989 Dec; 71(6):884-91. PubMed ID: 2585081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retinoic acid selectively inhibits the vascular permeabilizing effect of VPF/VEGF, an early step in the angiogenic cascade.
    Pal S; Iruela-Arispe ML; Harvey VS; Zeng H; Nagy JA; Dvorak HF; Mukhopadhyay D
    Microvasc Res; 2000 Sep; 60(2):112-20. PubMed ID: 10964585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The antiangiogenic agent neovastat (AE-941) inhibits vascular endothelial growth factor-mediated biological effects.
    Béliveau R; Gingras D; Kruger EA; Lamy S; Sirois P; Simard B; Sirois MG; Tranqui L; Baffert F; Beaulieu E; Dimitriadou V; Pépin MC; Courjal F; Ricard I; Poyet P; Falardeau P; Figg WD; Dupont E
    Clin Cancer Res; 2002 Apr; 8(4):1242-50. PubMed ID: 11948139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Central role of p53 on regulation of vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) expression in mammary carcinoma.
    Pal S; Datta K; Mukhopadhyay D
    Cancer Res; 2001 Sep; 61(18):6952-7. PubMed ID: 11559575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor-secreted vascular permeability factor/vascular endothelial growth factor influences photosensitizer uptake.
    Roberts WG; Hasan T
    Cancer Res; 1993 Jan; 53(1):153-7. PubMed ID: 8416739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular permeability factor/vascular endothelial growth factor inhibits anchorage-disruption-induced apoptosis in microvessel endothelial cells by inducing scaffold formation.
    Watanabe Y; Dvorak HF
    Exp Cell Res; 1997 Jun; 233(2):340-9. PubMed ID: 9194496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor growth modulation by sense and antisense vascular endothelial growth factor gene expression: effects on angiogenesis, vascular permeability, blood volume, blood flow, fluorodeoxyglucose uptake, and proliferation of human melanoma intracerebral xenografts.
    Oku T; Tjuvajev JG; Miyagawa T; Sasajima T; Joshi A; Joshi R; Finn R; Claffey KP; Blasberg RG
    Cancer Res; 1998 Sep; 58(18):4185-92. PubMed ID: 9751633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Further characterization of malignant glioma-derived vascular permeability factor.
    Criscuolo GR; Merrill MJ; Oldfield EH
    J Neurosurg; 1988 Aug; 69(2):254-62. PubMed ID: 3134521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular endothelial growth factor isoforms display distinct activities in promoting tumor angiogenesis at different anatomic sites.
    Guo P; Xu L; Pan S; Brekken RA; Yang ST; Whitaker GB; Nagane M; Thorpe PE; Rosenbaum JS; Su Huang HJ; Cavenee WK; Cheng SY
    Cancer Res; 2001 Dec; 61(23):8569-77. PubMed ID: 11731444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relevance of cell proliferation, vascular endothelial growth factor, and basic fibroblast growth factor production to angiogenesis and tumorigenicity in human glioma cell lines.
    Ke LD; Shi YX; Im SA; Chen X; Yung WK
    Clin Cancer Res; 2000 Jun; 6(6):2562-72. PubMed ID: 10873113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A highly conserved vascular permeability factor secreted by a variety of human and rodent tumor cell lines.
    Senger DR; Perruzzi CA; Feder J; Dvorak HF
    Cancer Res; 1986 Nov; 46(11):5629-32. PubMed ID: 3756910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.